Cargando…
Mass Spectrometry–Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective
Increasing proteomic studies focused on epithelial ovarian cancer (EOC) have attempted to identify early disease biomarkers, establish molecular stratification, and discover novel druggable targets. Here we review these recent studies from a clinical perspective. Multiple blood proteins have been us...
Autores principales: | Qian, Liujia, Sun, Rui, Xue, Zhangzhi, Guo, Tiannan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388592/ https://www.ncbi.nlm.nih.gov/pubmed/37209814 http://dx.doi.org/10.1016/j.mcpro.2023.100578 |
Ejemplares similares
-
Resistance prediction in high‐grade serous ovarian carcinoma with neoadjuvant chemotherapy using data‐independent acquisition proteomics and an ovary‐specific spectral library
por: Qian, Liujia, et al.
Publicado: (2023) -
High-throughput proteomic sample preparation using pressure cycling technology
por: Cai, Xue, et al.
Publicado: (2022) -
A pathway activity-based proteomic classifier stratifies prostate tumors into two subtypes
por: Sun, Rui, et al.
Publicado: (2023) -
Mass spectrometry-based proteomics techniques and their application in ovarian cancer research
por: Swiatly, Agata, et al.
Publicado: (2018) -
Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
por: Ryu, Joohyun, et al.
Publicado: (2021)